Viennese biotech company Marinomed Biotechnologie has licensed the rights of five drugs to a global pharmaceutical firm for the Chinese market. The drugs include three antiviral nasal sprays against common cold, influenza and colds in ...
Vienna-based biotech company Marinomed Biotechnologie's antiviral nasal spray, which is based on proprietary technology platform Mavirex, has secured the approval in Canada as a 'natural health product'. The approval of the spray followed ...